Post COVID-19 burden: focus on the short-term condition
- PMID: 37808352
- PMCID: PMC9746249
- DOI: 10.1097/HM9.0000000000000036
Post COVID-19 burden: focus on the short-term condition
Conflict of interest statement
Junhua Zhang and Boli Zhang are editorial board members of this journal.Xinyao Jin is an editorial office member and was excluded from the editorial process and publication decisions of this manuscript. Other authors declare no conflicts of interest.
Figures


References
-
- World Health Organization. WHO Coronavirus (COVID-19) dashboard; 2022. Available from: https://covid19.who.int. Accessed June 14, 2022.
-
- U.S. Food & Drug Administration. Coronavirus (COVID-19) | Drugs; 2022. Available from: https://www.fda.gov/drugs/emergency-preparedness-drugs/coronavirus-covid.... Accessed June 14, 2022.
-
- COVID19 Vaccine Tracker Team. 11 vaccines granted emergency use listing (EUL) by WHO; 2022. Available from: https://covid19.trackvaccines.org/agency/who/. Accessed June 14, 2022.
-
- Crook H, Raza S, Nowell J, et al. . Long COVID—mechanisms, risk factors, and management. BMJ. 2021;374:n1944. - PubMed
Publication types
LinkOut - more resources
Full Text Sources